Increased serum N(G)-hydroxy-L-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of an increased nitric oxide synthase activity

Annals of the Rheumatic Diseases

Volumn 56, Issue 5, 1997, Pages 330-332

  Wigand, Rainer ^a   Meyer, Jens ^a   Busse, Rudi ^a   Hecker, Markus ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) HYDROXYARGININE; NITRIC OXIDE SYNTHASE; ARGININE; BIOLOGICAL MARKER; DRUG DERIVATIVE; N(OMEGA) HYDROXYARGININE; N(OMEGA)-HYDROXYARGININE; NITRATE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ACUTE DISEASE; BLOOD; ENZYME ACTIVATION; ENZYMOLOGY; FEASIBILITY STUDY; METABOLISM;

ACUTE DISEASE; ARGININE; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; ENZYME ACTIVATION; FEASIBILITY STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NITRATES; NITRIC OXIDE SYNTHASE;

EID: 0030612791     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.5.330     Document Type: Article

References (15)

1. Ialenti A, Moncada S, Di Rosa M. Modulation of adjuvant arthritis by exogenous nitric oxide. Br J Pharmacol 1993;110:701-6.
2. Stichtenoth DO, Gutzki FM, Tsikas D, Selve N, Bode-Böger SM, Böger RH, et al. Increased urinary nitrite excretion in rats with adjuvant arthritis. Ann Rheum Dis 1994;53:547-9.
3. McCartney-Francis N, Allen JB, Mitzel DE, Albina JE, Xie Q-W, Nathan CF, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993; 178:749-54.
4. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 1994;37:1062-9.
5. Miesel R, Zuber M. Reactive nitrogen intermediates, antinuclear antibodies and copper-thionein in serum of patients with rheumatic diseases. Rheumatol Int 1993; 13:95-102.
6. Farrel AJ, Blake DR, Palmer RMJ, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
7. Stichtenoth DO, Fauler J, Zeidler H, Frölich JC. Urinary nitrite excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone. Ann Rheum Dis 1995;54:820-4.
8. Kaur H, Halliwell B. Evidence for nitric oxide-mediated damage in chronic inflammation: Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994;350:9-12.
9. Wenmalm A, Benthin G, Edlund A, Jungersten L, Kieler-Jensen N, Lundin S, et al. Metabolism and excretion of nitric oxide in humans - an experimental and clinical study. Circ Res 1993;73:1121-7.
10. G-hydroxy-L-arginine in rats treated with bacterial lipopolysaccharide. Eur J Pharmacol 1995; 275:R1-3.
11. G-hydroxy-L-arginine in alveolar macrophages - implications for the utilisation of L-arginine for nitric oxide synthesis. FEES Lett 1995;359:251-4.
12. Isenberg DA, Shoenfeld Y, Schwartz RS. Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum 1984;27: 132-8.
13. Gilliam MB, Sherman, MP, Griscavage JM, Ignarro LJ. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Anal Biochem 1993; 212:359-65.
14. Ritchie DM, Boyle JA, Mclnnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;147:393-406.
15. G-monomethyl-L-arginine. J Exp Med 1994; 179:651-60.